EPIUnit - Instituto de Saúde Pública, Universidade do Porto, Rua das Taipas.
Serviço de Epidemiologia - Instituto Português de Oncologia do Porto, Rua Dr. António Bernardino de Almeida.
Eur J Cancer Prev. 2020 May;29(3):215-221. doi: 10.1097/CEJ.0000000000000540.
Second primary cancers (SPCs) are an increasing concern among cancer survivors. In Northern Portugal, gastric cancer incidence is high, and alone corresponds to one in 10 SPCs diagnosed. Therefore, this study aims to estimate the contribution of gastric SPCs to the mortality of patients with a previous cancer. A population-based cohort of nongastric first primary cancer (FPC) patients from the North Region Cancer Registry of Portugal, diagnosed between 2000 and 2006, was followed for a gastric SPC until the end of 2012, and for death by any cause until the end of 2017. Patients with a gastric SPC (85 synchronous and 215 metachronous, diagnosed within one and >1 year after the FPC, respectively) were matched (1:3, by sex, five-year age group, year and site of FPC diagnosis) to those who did not develop a gastric SPC and were alive when the corresponding SPC was diagnosed. Significantly higher hazards for mortality [hazard ratio (95% confidence interval)] were observed among patients diagnosed with a synchronous [3.74 (2.69-5.21) in males and 3.36 (2.02-5.58) in females] or metachronous [6.93 (5.41-8.87) in males and 5.93 (4.04-8.72) in females] gastric SPC. The differences in the 10-year cumulative mortality between gastric SPC patients and those with no SPC were approximately 30% for synchronous and over 40% for metachronous gastric SPCs, corresponding to a 1.5- to 2-fold higher relative risk, respectively. In conclusion, cancer patients with a gastric SPC have a nearly two-fold higher risk of death over 10 years than those with a corresponding FPC only.
第二原发癌(SPCs)是癌症幸存者越来越关注的问题。在葡萄牙北部,胃癌发病率很高,单独占诊断出的 SPC 的十分之一。因此,本研究旨在评估胃 SPC 对先前患有癌症的患者死亡率的贡献。一项基于人群的葡萄牙北部癌症登记处的非胃第一原发癌(FPC)患者队列研究,诊断时间为 2000 年至 2006 年,随访胃 SPC 至 2012 年底,并随访任何原因导致的死亡至 2017 年底。患有胃 SPC(85 例同步和 215 例异时,分别在 FPC 后 1 年和>1 年内诊断)的患者与未发生胃 SPC 且在相应 SPC 诊断时存活的患者进行匹配(按性别、五年年龄组、FPC 诊断年份和部位 1:3 匹配)。观察到同步[男性 3.74(2.69-5.21),女性 3.36(2.02-5.58)]或异时[男性 6.93(5.41-8.87),女性 5.93(4.04-8.72)]胃 SPC 患者的死亡率[风险比(95%置信区间)]显著更高。与没有 SPC 的患者相比,患有同步或异时性胃 SPC 的患者在 10 年内的累积死亡率差异约为 30%,超过 40%,相应的相对风险分别为 1.5-2 倍。总之,患有胃 SPC 的癌症患者在 10 年内死亡的风险比仅患有相应 FPC 的患者高近 2 倍。